about
Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.CD4⁺ and CD8⁺ T cell-dependent antiviral immunity requires STIM1 and STIM2.Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.Nitric oxide and TNFα are critical regulators of reversible lymph node vascular remodeling and adaptive immune response.CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input.Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection.Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cellsNaive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection.Antigen presenting capacity of murine splenic myeloid cells.Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLsGinseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System.Dendritic cell behaviour in vivo: lessons learned from intravital two-photon microscopy.Peptide Based Vaccine Approaches for Cancer-A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory RegimenTh-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.Simulation and prediction of the adaptive immune response to influenza A virus infectionCell fusion: from hybridoma to dendritic cell-based vaccine.Biomarkers in Japanese encephalitis: a review.Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.From crucial to negligible: functional CD8⁺ T-cell responses and their dependence on CD4⁺ T-cell help.Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells.Functional Alteration of Natural Killer Cells and Cytotoxic T Lymphocytes upon Asbestos Exposure and in Malignant Mesothelioma Patients.Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.Peptide-based synthetic vaccines.Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.T-cell help dependence of memory CD8+ T-cell expansion upon vaccinia virus challenge relies on CD40 signaling.Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.M(IL-4) Tissue Macrophages Support Efficient Interferon-Gamma Production in Antigen-Specific CD8+ T Cells with Reduced Proliferative Capacity.Infectious Sporozoites of Plasmodium berghei Effectively Activate Liver CD8α+ Dendritic Cells.Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide.Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines.CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potentialCD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmissionThe Roles of CD4+ T Cells in Tumor Immunity
P2860
Q33713956-690D93E5-C960-43D4-A5ED-AC6C97E3A93AQ33730129-A53DB4D8-2D06-4F18-9EAC-9148ADE114BDQ34063120-AD960B4C-B261-4B5F-8A1B-D559CF6A563DQ34311528-BC8B8E05-03DF-4BF6-9360-FF9E04605E29Q34438014-6E32DAD9-057F-40C1-909E-7B1F15DCEA00Q34662099-F6195700-786F-4C1B-B4BF-BC6DB4945AA8Q35008302-EE78084C-5928-426E-B047-1DB0D126BE3FQ35147489-95857C07-17EA-466B-AD56-E14F3F1BDA9CQ35382523-BE9D800F-B4B1-474C-95A5-9FB220A8C772Q35688999-1474A2E8-CD61-4DBF-96FF-579F6F02490EQ35894221-77B37E8B-ECB4-4465-8035-67F8883DEA4CQ36246616-4A3ED43A-2271-42BE-945E-7272FC4A026EQ36403291-0EB60A32-AD88-497A-A164-225F3DD2F4C9Q36861216-3F63CE7F-1B07-4C0C-A5BC-FDAF6CF69325Q37145830-8FC6B49B-80E1-4FB5-A6B5-E1CA29C33D2EQ37148167-37E46A6B-B75A-45ED-AC93-23552C7D5C6EQ37176537-F97AF09F-9197-47F4-8640-CD612D1C2053Q37223456-A9E32FD9-F4B8-4CD3-A910-AD7022EF99A7Q37247935-DD377FA4-848F-4E4E-B111-68302EBAF076Q37259630-070BB9C5-181B-40BA-8A00-AEDADE590D99Q37425963-B071C815-33FB-4FE8-BE74-72B35C9FC62EQ37567900-891723C1-DDEE-4BBC-8714-D3F486C88AE4Q38005963-48A087D2-72FA-4C82-BC92-24C0323E48FCQ38039442-65FAC3AF-7E50-40B4-A06C-B861C1158EABQ38544787-5CDA9671-A178-4C08-9685-DB6FA3845C08Q38869738-E48198AE-BF80-4A72-B9E4-0FCDFC9D5D47Q38914295-03AC8943-BA31-4C66-B97B-33E8941FE605Q40339973-13907A6C-C2CB-472B-91CB-082610D8B248Q42263783-513F4956-8F4E-49A4-881F-FB72F574E902Q45201798-4137E4E8-533C-4355-834A-4EC5D37B2313Q46360981-FDC1A753-DD51-48DE-9155-084E801AF81EQ47564561-2411A8E7-35D3-413C-9670-E1A01E2A406AQ50199352-443F97B4-D8DB-4F23-BE94-430888BCC9D9Q52716742-0A343194-93A3-4F9B-8F81-777C621EC6BBQ53647622-693AE98A-BC88-47FB-B037-F79BE798D85AQ55333118-63A5E3F9-5B66-43C3-B133-CDA3EF5288A4Q57094380-07BF9234-B97B-42A7-A012-E6513B163B09Q57805454-B44657C8-EE4E-4E25-8A86-CFFEB9CBA427Q58689503-7D62F656-1958-452C-A66D-9F563B29602A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Helper T cells, dendritic cells and CTL Immunity.
@ast
Helper T cells, dendritic cells and CTL Immunity.
@en
type
label
Helper T cells, dendritic cells and CTL Immunity.
@ast
Helper T cells, dendritic cells and CTL Immunity.
@en
prefLabel
Helper T cells, dendritic cells and CTL Immunity.
@ast
Helper T cells, dendritic cells and CTL Immunity.
@en
P2093
P2860
P50
P1476
Helper T cells, dendritic cells and CTL Immunity.
@en
P2093
Christopher M Smith
Francis R Carbone
Georg Behrens
P2860
P356
10.1111/J.1440-1711.2004.01211.X
P577
2004-02-01T00:00:00Z